PACE
MANUFACTURERS’ REBATE
April 28, 2006
Act 128-1992 amending
the Lottery Fund Preservation Act, in part, requires all pharmaceutical
manufacturers to have in effect a rebate agreement with the PACE Program if
they wish to have their products covered.
In effecting the rebate provisions of Act 134-1996, PACE, the Chronic
Renal Disease Program (CRDP) and the Special Pharmaceutical Benefits Program
(SPBP) will preclude payment for all products marketed by those manufacturers
who either have not signed a PACE rebate agreement or have not complied with
the agreement provisions.
Please note the following manufacturer
is being added to PACE’s non-participating
list:
NABI
(North American Biological Inc) Labeler Code – 59730
NOTE: NABI has the exclusive rights to
Phoslo®.
All products of NABI, including Phoslo®, are no longer reimbursable effective May
29, 2006.
Questions
regarding this bulletin should be directed to:
Nabi
Biopharmaceuticals
Corporate
Headquarters and Manufacturing Facility
5800 Park of
Commerce Blvd., N.W.
Boca Raton,
Florida
1-800-865-1766